Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Uretral Resistivt Indeks (URI): En Ny Parameter til Diagnostisering af Uretral Obstruction (URI)

1. november 2026 opdateret af: Yusuf Gökkurt, Ankara City Hospital Bilkent

Uretral Resistiv Index (URI): En Ny Uroflowmetrisk Parameter i den Ikke-invasive Diagnostik af Uretral Obstruction

This prospective observational study aims to evaluate the diagnostic accuracy of a new, non-invasive uroflowmetry parameter called the Urethral Resistive Index (URI) for detecting urethral stricture in men. Currently, diagnosing urethral stricture often requires invasive procedures like surgery or pressure-flow studies. This research seeks to develop URI as a practical and painless screening tool that could reduce the need for such invasive interventions.

Study Procedures:

A total of 60 male participants (30 with suspected urethral stricture and 30 healthy volunteers) will be enrolled. Participants will undergo two standard, non-invasive uroflowmetry (voiding) tests. The first test is a routine natural voiding session. The second test involves a "forced voiding" (Valsalva maneuver) once the participant feels a sufficient urge to urinate again. The URI is then calculated by comparing the flow rates of these two sessions.

Goals and Benefits: The primary goal is to determine the optimal "cut-off" value of the URI that accurately identifies a surgically proven urethral stricture. By demonstrating URI's effectiveness, the study aims to expedite the diagnostic process and spare patients from unnecessary invasive tests. The procedure involves minimal risk, primarily temporary discomfort or psychological stress during the voiding tests

Studieoversigt

Status

Rekruttering

Betingelser

Detaljeret beskrivelse

This methodological study is designed as a prospective, cross-sectional, and observational diagnostic accuracy study. The primary objective is to evaluate the clinical validity of the Urethral Resistive Index (URI), a novel non-invasive parameter, in the diagnosis of urethral stricture.

Study Population and Groups:

The study will include a total of 60 male participants aged between 18 and 80 years.

Stricture Group (n=30): Patients planned for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the presence of the stricture is confirmed intraoperatively.

Control Group (n=30): Healthy male volunteers without lower urinary tract symptoms, matched for age.

Methodology: The study focuses on comparing standard uroflowmetry with "forced" uroflowmetry using the Valsalva maneuver. All clinical and uroflowmetric parameters will be collected at the Ankara Bilkent City Hospital Urology Clinic.

Natural Uroflowmetry: Participants will perform a standard uroflowmetry test. Forced Uroflowmetry: After reaching sufficient bladder fullness again, participants will perform a second test using the Valsalva maneuver (forced voiding).

Calculation: The URI will be calculated using the formula:

URI= Qmax,forced/ Qmax,normal

Statistical Analysis: The diagnostic performance of the URI will be evaluated using Receiver Operating Characteristic (ROC) curve analysis. The Area Under the Curve (AUC) will be calculated, and the optimal cut-off value for determining urethral stricture will be identified with corresponding sensitivity and specificity values. Correlation between URI and clinical symptom scores, such as the International Prostate Symptom Score (IPSS), will also be analyzed.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

60

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

    • Universiteler
      • Ankara, Universiteler, Tyrkiet (Türkiye), 06800
        • Rekruttering
        • Ankara Bilkent City Hospital
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 80 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Han

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

The study population consists of 60 male participants, aged 18 to 80 years, recruited from the Urology Outpatient Clinic at Ankara Bilkent City Hospital. The population is divided into two distinct groups: a Stricture Group (n=30) comprising patients with suspected urethral stricture whose diagnosis is confirmed intraoperatively during scheduled surgery, and a Control Group (n=30) comprising healthy male volunteers with a similar age distribution and no lower urinary tract symptoms. Participants are selected based on their clinical presentation and willingness to undergo a specialized two-stage uroflowmetry protocol.

Beskrivelse

Inclusion Criteria:

  • Male participants aged between 18 and 80 years.
  • For the Stricture Group: Patients scheduled for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the diagnosis is confirmed intraoperatively.
  • For the Control Group: Healthy male volunteers without any lower urinary tract symptoms.
  • Voluntary signing of the Informed Consent Form.

Exclusion Criteria:

  • Voiding volume less than 150 mL.
  • Causes of obstruction other than stricture, such as Benign Prostatic Hyperplasia (BPH).
  • Diagnosis of neurogenic bladder dysfunction or a history of neurological disease affecting bladder function.
  • Presence of severe comorbidities.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Stricture Group

Patients with suspected urethral stricture scheduled for surgery (urethroplasty or internal urethrotomy), with the diagnosis confirmed intraoperatively.

Performing natural and forced (Valsalva) uroflowmetry sessions to calculate the Urethral Resistive Index.

Control Group

Healthy male volunteers in a similar age range as the stricture group, without any lower urinary tract symptoms.

Performing natural and forced (Valsalva) uroflowmetry sessions to calculate the Urethral Resistive Index.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Urethral Resistive Index (URI)
Tidsramme: At the time of the uroflowmetry procedure (Baseline)

A novel non-invasive uroflowmetric parameter calculated to assess the resistance of the urethra during voiding. It is derived using the formula: URI=Qmax,natural/Qmax,forced.

At the time of the uroflowmetry procedure (Baseline)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

10. februar 2026

Primær færdiggørelse (Anslået)

10. februar 2027

Studieafslutning (Anslået)

10. marts 2027

Datoer for studieregistrering

Først indsendt

5. februar 2026

Først indsendt, der opfyldte QC-kriterier

5. februar 2026

Først opslået (Faktiske)

11. februar 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

3. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

1. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

To protect participant privacy and maintain data confidentiality according to local institutional regulations

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner